ABOS
Acumen Pharmaceuticals, Inc. · Healthcare · Market cap $211.2M(Price slightly stale)
Insiders sold $90K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Jun 17, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$625K
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Latest filing
Jun 17, 2026
Porter Derrell
Acumen Pharmaceuticals, Inc. (ABOS) has 37 SEC Form 4 filings (70 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Jun 17, 2026.
Inside the rolling window, 9 insiders at Acumen Pharmaceuticals, Inc. reported no open-market purchases and 44 open-market sales totaling $625K. The most active filer is Chief Legal Officer & Corp Sec Meisner Derek M with 13 filings. Insiders have net sold $625K over the trailing 6 months. The most recent open-market filing is a sale of 6,460 shares by Director Porter Derrell, dated Jun 15, 2026, worth $15K.
- Industry:Biotechnology
- CEO:Daniel J. O'Connell
- Employees:61
- HQ:Newton, MA, US
- IPO:2021-07-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
Porter DerrellFirst filing | Director | Sale | 6,460 | $15K | Jun 17 | +29.8% | SEC ↗ |
Porter DerrellFirst filing | Director | Sale | 12,800 | $30K | Jun 17 | +29.8% | SEC ↗ |
Porter DerrellFirst filing | Director | Sale | 13,040 | $30K | Jun 17 | +29.8% | SEC ↗ |
Fountain Nathan BFirst filing | Director | Sale | 6,400 | $14K | Jun 10 | +30.4% | SEC ↗ |
| Chief Legal Officer & Corp Sec | Sale | 2,090 | $7K | Mar 10 | -13.1% | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 9,406 | $28K | Mar 3 | -11.8% | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 15,085 | $45K | Jan 28 | +3.9% | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 2,671 | $8K | Jan 28 | +3.9% | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 2,247 | $4K | Jan 23 | +47.5% | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 1,054 | $2K | Jan 23 | +47.5% | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 5,633 | $11K | Jan 23 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 2,331 | $4K | Jan 23 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 895 | $2K | Jan 23 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 2,315 | $4K | Jan 23 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 462 | $850 | Jan 23 | — | SEC ↗ | |
| CFO & Chief Business Officer | Sale | 2,473 | $4K | Jan 23 | — | SEC ↗ | |
| CFO & Chief Business Officer | Sale | 1,687 | $3K | Jan 23 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 9,346 | $17K | Jan 23 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 2,689 | $5K | Jan 23 | — | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 36,911 | $67K | Jan 12 | — | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 5,200 | $9K | Jan 12 | — | SEC ↗ | |
| Chief Legal Officer & Corp Sec | Sale | 8,548 | $15K | Jan 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 8,143 | $15K | Jan 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 12,941 | $23K | Jan 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 5,388 | $9K | Jan 12 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ABOS have?
Acumen Pharmaceuticals, Inc. (ABOS) has 37 SEC Form 4 filings (70 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Jun 17, 2026.
When was the most recent SEC Form 4 filing for ABOS?
The most recent Form 4 filing for ABOS on Tracefour is dated Jun 17, 2026.
Who is the most active insider at ABOS?
The most active SEC Form 4 filer at ABOS in the rolling window is Chief Legal Officer & Corp Sec Meisner Derek M, with 13 filings.
What is the net insider flow at ABOS over the last 6 months?
Over the trailing 180 days, insiders at ABOS have net sold $625K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ABOS in the current window?
Inside the rolling window, insiders at ABOS bought $0 and sold $625K based on SEC Form 4 filings.
Can I get alerts for ABOS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Acumen Pharmaceuticals, Inc. (ABOS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Acumen Pharmaceuticals, Inc. is in the Healthcare sector.